GlaxoSmithKline PLC (GSK:NYSE)

The debate over whether antidepressants play a role in suicides and homicides has taken twists and turns over the years.

For more than a year, John Mark Felton chatted online with an Anchorage father of two, planning a visit to meet the family so he could molest a 6-year-old boy, according to documents filed in federal court. He talked about a scene in which the father would molest his 7-year-old girl and Felton, a Briton living in Boston, would molest the 6-year-old.

From Barcelona to Seoul, urban science parks are being built to lure the best minds and the industries of tomorrow

From Barcelona to Seoul, urban science parks are being built to lure the best minds and the industries of tomorrow

Moody's Investors Service issued a negative opinion on the pharmaceutical industry Thursday, saying drugmaker credit ratings will be under pressure until early 2012 because they won't be able to fully replace revenue from best-sellers that go off-patent.

Federal health experts said Wednesday an updated version of Pfizer's best-selling anti-infection vaccine is safe and effective for infants and toddlers, despite company studies that failed to meet certain goals. The Food and Drug Administration's panel of vaccine experts voted 10-1 in favor of Pfizer's Prevnar 13 to protect against pneumococcal disease.

Green Hope, Chapel Hill and Pittsboro Northwood go on the road tonight for the N.C. High School Athletic Association boys soccer semifinal games. Green Hope is at Southern Pines Pinecrest for a 4-A game, while Chapel Hill and Northwood will play within a few miles of each other in the 3-A and 2-A semis. Green Hope and Pinecrest have survived several one-goal games.

A small Durham company developing new drugs to treat ailments such as ADHD, hypertension and insomnia has been acquired by an Atlanta pharmaceuticals firm for $29million. Addrenex Pharmaceuticals was founded in 2006 by a drug researcher born in Lebanon and a Charlotte physician who connected through a mutual friend.

Malaria. Tuberculosis. Many could be on the market in five years or less. Contrast that with five years ago, when so many companies had abandoned the vaccine business that half the U.S. supply of flu shots was lost because of contamination at one of the two manufacturers left. Vaccines are no longer a sleepy, low-profit niche in a booming drug industry.